Biofil Chemicals & Pharmaceuticals (BOM:524396) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 29, 2026)


BOM:524396 Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
65 GF Score
Price ₹35.98
GF Value ₹41.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Biofil Chemicals & Pharmaceuticals's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:524396 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofil Chemicals & Pharmaceuticals Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Margin of Safety % (DCF Earnings Based) falls into.


BOM:524396
65GF Score
Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biofil Chemicals & Pharmaceuticals (BOM:524396) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹35.98 is trading 14% below its estimated GF Value™ of ₹41.83. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:524396:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹41.83 vs. price of ₹35.98 (14% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the BOM:524396 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges BIOFILCHEM:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
65GF Score

Get the complete analysis for BOM:524396

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.98
Price
₹41.83
GF Value